Explore BrainMass

Explore BrainMass

    Bayes Rule / Bayesian

    Not what you're looking for? Search our solutions OR ask your own Custom question.

    This content was COPIED from BrainMass.com - View the original, and get the already-completed solution here!

    Bayesian Analysis of a Law case (taken from Rossman and Short, 1995, Journal of Statistics Education). Joseph Jameison was charged with multiple rapes in 1987 in Allegheny County in the US. DNA evidence from the scenes of the crimes revealed that the attacker displayed the genetic marker PGM2+1- in his DNA. This marker has only a 0.32% prevalence in the general population.
    (a) Discuss how you might choose a prior probability that Jameison is guilty. Explain and defend your choice (do not set a specific number yet).
    (b) Update your prior with the observed information. Display the full formula for Bayes' rule in terms of the as yet unknown prior Pr(guilty).
    (c) Display the posterior probability of guilt using a range of suitable values for the prior Pr(guilty).
    (d) Say that a jury wants to be at least 97.5% sure of guilt before returning a guilty verdict. What is the smallest prior probability of guilt that could be chosen to ensure this level of probability.
    (e) There are 4,622 males living in Allegheny County. Given that we have found 1 male with PGM2+1- in his DNA, what is the probability that other males in the county also display this marker?
    (f) Should Jameison be found guilty on the DNA evidence alone? Discuss.

    © BrainMass Inc. brainmass.com March 4, 2021, 8:02 pm ad1c9bdddf
    https://brainmass.com/statistics/bayesian-probability/bayes-rule-bayesian-139953

    Attachments

    Solution Summary

    Bayesian Analysis of a Law case (taken from Rossman and Short, 1995, Journal of Statistics Education). Joseph Jameison was charged with multiple rapes in 1987 in Allegheny County in the US. DNA evidence from the scenes of the crimes revealed that the attacker displayed the genetic marker PGM2+1- in his DNA. This marker has only a 0.32% prevalence in the general population.

    $2.49

    ADVERTISEMENT